Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.
Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
Mariana Oncology is a biotechnology research industry.
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits.
AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.
Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.
Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.
DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.
IgGenix is a biotechnology company.
Rimidi is a health IT platform that enables virtual, personalized management of cardiometabolic diseases.
Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Arkuda Therapeutics is a pharmaceutical company.
Iterative Health develops technology that can benefit patients anywhere, regardless of socioeconomic or geographic barriers.
Regor Therapeutics is an international biotech company that focuses in the therapeutic areas of oncology, metabolic and autoimmune diseases.
DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.
The Indianapolis Cultural Trail is a construction entity that focuses on developing urban trails and linear parks.
Faze Medicines is a biotechnology company.
Sigilon Therapeutics is a biotech company that specializes in creating immune-privileged products for treating acute and chronic diseases.
Centrexion Therapeutics is a late clinical-stage biopharmaceutical company addressing the treatment of chronic pain.
Companion Medical develops a technology designed for those living with Type 1 or Type 2 insulin-dependent diabetes.
Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.
Eli Lilly has invested in 169 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Medical, Genetics. The firm invests across 25 different industry categories.
Among tracked funding rounds, Mariana Oncology received $175.0M in a Series B round. Eli Lilly's total known invested capital is $11.1B.
Eli Lilly's average investment size is $69.2M across its portfolio of 169 companies.
Recent Eli Lilly portfolio additions include Blacksmith Medicines, Firefly Bio, ViaNautis, Sitryx Therapeutics, Mariana Oncology. These companies were founded in 2020 or later.